Let’s meet the inspiring father-daughter duo who share a passion for BMX riding and a goal to help defeat type 1 diabetes. Daniel was diagnosed with type 1 diabetes (T1D) at a young age, but that didn’t stop him from becoming a proud father of two, a motorcycle racer, and a mentor and supporter to […]
Last year, JDRF appointed Dr Kirstine Bell from the Charles Perkins Centre, University of Sydney, to lead a pilot study to screen for risk of type 1 diabetes in the general population. Today, Dr Bell launched the national screening project and revealed new details about what it will involve. “Children are often diagnosed with type […]
UPDATED September 2022 Australia has rolled out two COVID-19 vaccines – one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated. With vaccines now being offered to people with T1D, we’ve gathered all the information you need to […]
JDRF Australia are delighted to welcome Professor Fabienne Mackay to the Board of JDRF Australia. Professor Mackay, who joined the Board at the June 2021 Board meeting, will also play an important role on JDRF’s Board Research Committee, evaluating and ensuring JDRF continues to support the best local research into type 1 diabetes (T1D). Prof. Mackay obtained her PhD from Louis Pasteur University in Strasbourg, France and has more than […]
JDRF and The Leona M. and Harry B. Helmsley Charitable Trust are excited to announce more than $1.2 million in new funding for three outstanding early-mid career Australian researchers. The ENDIA Early-Mid Career Science Accelerator Awards will support the researchers in carrying out new projects using samples collected as part of the ENDIA study, the […]
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. This month, the American Diabetes Association held their 81st Scientific Sessions. The world’s top type 1 […]
The past 12 months has been challenging in so many ways, particularly for our community. However, as with every challenge the resilient T1D community has been faced with, the pandemic, and the challenges it brought with it, has certainly not defined us. During this time, we’ve continued to see an almost limitless amount of courage, strength, and resilience from all of you. The challenges of the past 12 months and the impact COVID-19 has had […]
Today, we are excited to announce that two important members of the JDRF community have been appointed members of the Order of Australia as part of the Queen’s Birthday 2021 Honours List. Helen Maxwell-Wright We’re proud to be celebrating Helen Maxwell-Wright, Chair of our Victorian State Leadership Group and major supporter of type 1 diabetes […]
The Medtronic Minimed 770G will be added to the Federal Governments Insulin Pump Program – a significant step toward achieving our goal of more technology for more people through our policy agenda. So, what does this mean for you?
Australians living with type 1 diabetes (T1D) are disproportionately affected by a psychological phenomenon called decision fatigue, which hinders their ability to make vital decisions – placing them at greater risk of life-threatening complications such as heart attack and kidney disease.1 People living with T1D must make an extra 180 decisions every day compared to […]
A research breakthrough, funded by JDRF, has shown a promising future for the prevention of type 1 diabetes. Findings from a study by TrialNet show that the immunotherapy drug teplizumab can delay type 1 diabetes diagnosis a median of 2 years in children and adults at high risk. The study showed that teplizumab interferes with […]
First report of its kind in a decade shows the incidence of type 1 diabetes (T1D) in Australia has grown to more than 125,000 people today, with the economic cost now standing at a staggering $2.9 billion per year. The report also highlights the significant financial impact of complications of the disease, with the presence of just two complications increasing the cost to the economy more than fourfold. There is also a serious mental health impact of living with T1D, with patients five times […]
For the past 100 years, the only effective treatment for type 1 diabetes (T1D) has been insulin. For the more than 125,000 Australians living with T1D insulin is a lifesaving medication that regulates the amount of sugar in the bloodstream. Insulin is something that people who don’t live with T1D produce naturally. Outside of the lifelong regimen of insulin infusions and blood sugar checks, people with T1D are more likely to […]
For the more than 125,000 Australians that live with type 1 diabetes (T1D) – insulin is more than a lifechanging treatment. It’s a lifesaving one. A substance made naturally in the body for those who don’t live with diabetes, insulin regulates the amount of sugar in the blood – something that can change depending on […]
Each year, JDRF offers a PhD Top-Up Scholarship to provide additional funding for PhD students pursuing type 1 diabetes research. Since its inception, the scholarship has helped more than 20 outstanding students kick-start a career in T1D research. Over the next few weeks, we’re catching up with some former recipients to find out what they’ve […]
Young adults and low-income families with type 1 diabetes (T1D) are facing immense barriers to using and retaining vital technology to manage their disease, with inequitable access and high costs putting them at risk of financial burden and life-threatening complications. The financial burden of managing T1D is exacerbating mental health issues with half of those […]